IL163577A0 - Interferon beta-like molecules for treatment of stroke - Google Patents

Interferon beta-like molecules for treatment of stroke

Info

Publication number
IL163577A0
IL163577A0 IL16357703A IL16357703A IL163577A0 IL 163577 A0 IL163577 A0 IL 163577A0 IL 16357703 A IL16357703 A IL 16357703A IL 16357703 A IL16357703 A IL 16357703A IL 163577 A0 IL163577 A0 IL 163577A0
Authority
IL
Israel
Prior art keywords
stroke
molecules
treatment
interferon beta
interferon
Prior art date
Application number
IL16357703A
Other languages
English (en)
Original Assignee
Maxygen Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Aps filed Critical Maxygen Aps
Publication of IL163577A0 publication Critical patent/IL163577A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16357703A 2002-03-12 2003-02-28 Interferon beta-like molecules for treatment of stroke IL163577A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200200371 2002-03-12
PCT/DK2003/000127 WO2003075944A2 (en) 2002-03-12 2003-02-28 Interferon beta-like molecules for treatment of stroke

Publications (1)

Publication Number Publication Date
IL163577A0 true IL163577A0 (en) 2005-12-18

Family

ID=27798724

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16357703A IL163577A0 (en) 2002-03-12 2003-02-28 Interferon beta-like molecules for treatment of stroke

Country Status (10)

Country Link
US (1) US20060083715A1 (xx)
EP (1) EP1487478A2 (xx)
JP (1) JP2005519946A (xx)
KR (1) KR20040104504A (xx)
AR (1) AR038900A1 (xx)
AU (1) AU2003214019A1 (xx)
CA (1) CA2477577A1 (xx)
IL (1) IL163577A0 (xx)
MX (1) MXPA04008798A (xx)
WO (1) WO2003075944A2 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE471720T1 (de) 2003-03-28 2010-07-15 Faron Pharmaceuticals Oy Erhöhung des adenosin-spiegels durch cytokin- induzierte expression von cd73
CA2576030A1 (en) * 2004-08-09 2006-02-23 Alios Biopharma Inc. Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
US7597884B2 (en) * 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
HUE038947T2 (hu) * 2005-08-26 2018-12-28 Ares Trading Sa Eljárás glikozilált béta-interferon elõállítására
FI20051003A0 (fi) * 2005-10-07 2005-10-07 Faron Pharmaceuticals Oy Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi
WO2008137471A2 (en) 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
CN109134642A (zh) * 2011-10-01 2019-01-04 株式会社糖锁工学研究所 加成糖链的多肽及含有该多肽的医药组合物
ES2687801T3 (es) 2013-03-29 2018-10-29 Glytech, Inc. Polipéptido presentando cadenas de azúcares sialiladas unidas al mismo
WO2016071911A1 (en) * 2014-11-06 2016-05-12 Yeda Research And Development Co. Ltd. Treatment of cns inflammatory disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2210622A1 (en) * 1995-11-17 1997-05-29 Toray Industries, Inc. An agent protecting endothelial cells
JPH09151137A (ja) * 1995-12-01 1997-06-10 Toray Ind Inc 平滑筋細胞増殖抑制剤
DE60129472T2 (de) * 2001-04-03 2008-04-17 U-Cytech B.V. Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
AU2002310922A1 (en) * 2001-05-04 2002-11-18 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia

Also Published As

Publication number Publication date
MXPA04008798A (es) 2004-11-26
WO2003075944A2 (en) 2003-09-18
WO2003075944A3 (en) 2004-03-18
US20060083715A1 (en) 2006-04-20
CA2477577A1 (en) 2003-09-18
AR038900A1 (es) 2005-02-02
KR20040104504A (ko) 2004-12-10
JP2005519946A (ja) 2005-07-07
AU2003214019A1 (en) 2003-09-22
EP1487478A2 (en) 2004-12-22

Similar Documents

Publication Publication Date Title
HK1074784A1 (en) Treatment of mucositis
AU2003236991A8 (en) Representations of processes
HK1097704A1 (en) Process for producing protein hydrolysate and protein hydrolysate
ZA200600025B (en) Methods and compositions for interferon therapy
AU2003254641A8 (en) Interferon beta-like molecules for treatment of cancer
IL152865A0 (en) Peristalic pump
IL163577A0 (en) Interferon beta-like molecules for treatment of stroke
EP1575606A4 (en) TREATMENT OF OSTEOARTHRITIS
IL172184A0 (en) Interferon gamma - like protein
GB0306309D0 (en) Method of treatment
GB0302572D0 (en) Method of treatment
EP1668146A4 (en) HOMOGENEOUS POPULATIONS OF MOLECULES
GB2392746B (en) Comparison of molecules using field points
IL171945A0 (en) Iodopyrazolyl carboxanilides
GB0221157D0 (en) Novel treatment
GB0217493D0 (en) Novel methods of treatment
GB0223153D0 (en) Prestressing of components
GB0219835D0 (en) Treatment of anemia
GB0311158D0 (en) Respiratory interferon process
TW558019U (en) Structure of illumination apparatus
GB0304021D0 (en) Treatment of hypertension
GB0329357D0 (en) Treatment of materials
GB0313022D0 (en) Ischaemic stroke treatment
GB0311667D0 (en) Ischaemic stroke treatment
GB0311622D0 (en) Ischaemic stroke treatment